SEC Form 4 · accession 0001179110-15-003334

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman and CEO · Director

Period of report

Feb 20, 2015

Accepted (ET)

Feb 24, 2015 · 5:46 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value^F1	Feb 20, 2015	A	132,978	$0.00	A	1,546,063	D
Common shares without par value^F2	holding	—	—		—	27,840	I	Profit Sharing Trust
Common shares without par value^F3	holding	—	—		—	8,343	I	By son
Common shares without par value^F3	holding	—	—		—	8,252	I	By son

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F4	$47.00	Feb 20, 2015	A	937,031	A	Feb 20, 2016	Feb 19, 2025	Common shares	937,031	937,031	D

F1These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2015.
F3The reporting person disclaims beneficial ownership of all securities held by his sons.
F4Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 312,344 on 2/20/16, 312,343 on 2/20/17, and 312,344 on 2/20/18.